OmniAb, Inc.
OABINASDAQHealthcare● Active
$2.28
$-0.20(-8.06%)
Market Cap$271526418
P/E Ratio—
52W High$2.79
52W Low$1.3
OmniAb, Inc. (OABI) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
OABI · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 7, 2026EPS Actual
-$0.06
Est. -$0.10 · +40.0%
Revenue
$0.01B
Est. $0.01B · +157.6%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 7, 2026
After Market Close
▲ Beat EPS▲ Beat Revenue✓ 1-Quarter EPS Beat Streak
OABI reports quarterly as a NASDAQ-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$0.09
Rev. $41.31B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$0.09
Rev. Est.$41.31B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 6, 2026 | -$0.11 | — | — | — | $0.00B | — |
| ▲ Q2 FY2026 | May 7, 2026 | -$0.10 | -$0.06 | +40.0% | $0.01B | $0.01B | +157.6% |
| ▼ Q1 FY2026 | Mar 4, 2026 | -$0.08 | -$0.11 | -37.5% | $0.01B | $0.01B | -7.0% |
| ▼ Q4 FY2025 | Nov 4, 2025 | -$0.14 | -$0.14 | -2.9% | $0.00B | $0.01B | -60.3% |
| ▼ Q3 FY2025 | Aug 6, 2025 | -$0.14 | -$0.15 | -7.1% | $0.00B | $0.01B | -30.9% |
| — Q2 FY2025 | May 8, 2025 | -$0.17 | -$0.17 | +0.0% | $0.00B | $0.00B | -7.5% |
| ▲ Q1 FY2025 | Mar 18, 2025 | -$0.13 | -$0.12 | +7.7% | $0.01B | $0.01B | +65.3% |
| ▼ Q4 FY2024 | Nov 12, 2024 | -$0.14 | -$0.16 | -14.3% | $0.00B | $0.01B | -58.8% |
Q3 FY2026
Aug 6, 2026
EPS Actual
—
EPS Est.
-$0.11
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 7, 2026Beat
EPS Actual
-$0.06
EPS Est.
-$0.10
EPS Surpr.
+40.0%
Revenue
$0.01B
Q1 FY2026
Mar 4, 2026Miss
EPS Actual
-$0.11
EPS Est.
-$0.08
EPS Surpr.
-37.5%
Revenue
$0.01B
Q4 FY2025
Nov 4, 2025Miss
EPS Actual
-$0.14
EPS Est.
-$0.14
EPS Surpr.
-2.9%
Revenue
$0.00B
Q3 FY2025
Aug 6, 2025Miss
EPS Actual
-$0.15
EPS Est.
-$0.14
EPS Surpr.
-7.1%
Revenue
$0.00B
Q2 FY2025
May 8, 2025
EPS Actual
-$0.17
EPS Est.
-$0.17
EPS Surpr.
+0.0%
Revenue
$0.00B
Q1 FY2025
Mar 18, 2025Beat
EPS Actual
-$0.12
EPS Est.
-$0.13
EPS Surpr.
+7.7%
Revenue
$0.01B
Q4 FY2024
Nov 12, 2024Miss
EPS Actual
-$0.16
EPS Est.
-$0.14
EPS Surpr.
-14.3%
Revenue
$0.00B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $-0.14 | $-0.09 | $-0.05 | 1 |
| Q3 FY2027 | $-0.14 | $-0.09 | $-0.05 | 1 |
| Q2 FY2027 | $-0.14 | $-0.09 | $-0.05 | 1 |
| Q1 FY2027 | $-0.12 | $-0.08 | $-0.05 | 1 |
| Q4 FY2026 | $-0.18 | $-0.12 | $-0.07 | 1 |
| Q3 FY2026 | $-0.13 | $-0.12 | $-0.11 | 3 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $0.0B | $0.0B | $0.0B | 2 |
| Q3 FY2027 | $0.0B | $0.0B | $0.0B | 2 |
| Q2 FY2027 | $0.0B | $0.0B | $0.0B | 2 |
| Q1 FY2027 | $0.0B | $0.0B | $0.0B | 2 |
| Q4 FY2026 | $0.0B | $0.0B | $0.0B | 2 |
| Q3 FY2026 | $0.0B | $0.0B | $0.0B | 5 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | May 7, 2026 | +40.0% | $1.43 | $1.47 | +2.80% |
| ▼ Q1 FY2026 | Mar 4, 2026 | -37.5% | $1.73 | $1.81 | +4.62% |
| ▼ Q4 FY2025 | Nov 4, 2025 | -2.9% | $1.48 | $1.48 | +0.00% |
| ▼ Q3 FY2025 | Aug 6, 2025 | -7.1% | $2.04 | $1.93 | -5.39% |
| ▲ Q2 FY2025 | May 8, 2025 | +0.0% | $1.53 | $1.57 | +2.61% |
| ▲ Q1 FY2025 | Mar 18, 2025 | +7.7% | $3.17 | $3.19 | +0.63% |
| ▼ Q4 FY2024 | Nov 12, 2024 | -14.3% | $4.60 | $4.49 | -2.39% |
| ▲ Q3 FY2024 | Aug 8, 2024 | +27.8% | $4.06 | $4.29 | +5.67% |
Q2 FY2026+2.80%
Report Date
May 7, 2026
EPS Beat/Miss
+40.0%
Price Before
$1.43
Price After
$1.47
Q1 FY2026+4.62%
Report Date
Mar 4, 2026
EPS Beat/Miss
-37.5%
Price Before
$1.73
Price After
$1.81
Q4 FY2025+0.00%
Report Date
Nov 4, 2025
EPS Beat/Miss
-2.9%
Price Before
$1.48
Price After
$1.48
Q3 FY2025-5.39%
Report Date
Aug 6, 2025
EPS Beat/Miss
-7.1%
Price Before
$2.04
Price After
$1.93
Q2 FY2025+2.61%
Report Date
May 8, 2025
EPS Beat/Miss
+0.0%
Price Before
$1.53
Price After
$1.57
Q1 FY2025+0.63%
Report Date
Mar 18, 2025
EPS Beat/Miss
+7.7%
Price Before
$3.17
Price After
$3.19
Q4 FY2024-2.39%
Report Date
Nov 12, 2024
EPS Beat/Miss
-14.3%
Price Before
$4.60
Price After
$4.49
Q3 FY2024+5.67%
Report Date
Aug 8, 2024
EPS Beat/Miss
+27.8%
Price Before
$4.06
Price After
$4.29
Avg Beat Reaction+2.93%
Avg Miss Reaction-0.79%
Beat Rate4 / 8 quarters
Largest Move+5.67% (Q3 FY2024)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: OABI ends December
OmniAb, Inc. (OABI) most recently reported earnings on May 7, 2026 for Q2 FY2026, posting EPS of $-0.06 — beating the analyst consensus of $-0.10 by +40.0%. The next OABI earnings date is expected around September 1, 2026.
Each quarter, investors track OABI earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. OABI revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
OABI's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
OABI earnings · 5 questionsOmniAb, Inc.'s next earnings report is expected around September 1, 2026. OABI typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; OABI historically reports after market close (AMC).
OABI earnings datewhen is OABI earningsOABI next earnings datewhen does OABI report earningsOABI earnings calendar
▸ Source: FMP · OmniAb, Inc. SEC filings · US GAAP · OmniAb, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026